Peptide Industry intermediate
Peptide Pharmacovigilance
Post-marketing safety monitoring and pharmacovigilance for peptide therapeutics.
By Encyclopeptide Editorial | 1 min read
pharmacovigilance safety monitoring post-market
Overview
Pharmacovigilance for peptide therapeutics involves monitoring safety signals, managing risks, and ensuring continued benefit-risk balance.
Key Activities
- Adverse event reporting: Spontaneous and solicited reports
- Signal detection: Identifying new safety concerns
- Risk management: REMS and risk minimization
- Periodic safety reports: PBRER and PSUR submissions
Peptide-Specific Concerns
- Injection site reactions
- Immunogenicity and anti-drug antibodies
- Hypoglycemia risk with insulin peptides
- Cardiovascular effects of GLP-1 agonists
Regulatory Requirements
FDA, EMA, and other agencies require ongoing pharmacovigilance throughout the product lifecycle.
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Pharmacovigilance with interactive quizzes on Wikipept.
Take a Quiz on Wikipept